Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


DeLauro Presses Hamburg On FDA’s Reagan-Udall Funding

This article was originally published in The Tan Sheet

Executive Summary

No funds have been transferred to the foundation and no decision has been made about how much, FDA Commissioner Hamburg says, but DeLauro asks why Reagan-Udall should receive guaranteed funds, when other foundations and nonprofits have to compete.

You may also be interested in...

Appropriators Suggest Moving Food Safety Out Of FDA, Question User Fee Proposals

A House Appropriations Agriculture/FDA subcommittee member suggests splitting food authorities out of FDA to sharpen its pharma and device focus and allow USDA to handle food safety enforcement. Chairman Kingston praises the budget request’s restraint, but members question proposed user fees.

When Reagan-Udall Foundation Gets Started, Funding Is First On To-Do List

The FDA Amendments Act created an abundance of oversight functions to organize in the broad new powers it authorized to FDA for ensuring drug safety, but the act also provides the agency with an outside partner - the Reagan-Udall Foundation

US FDA Exploring Options To Improve Study Of Drugs In Elderly

New incentives will most likely not be the immediate focus, but working group to explore ideas on enhancing understanding of drug effects in elderly populations will likely be formed by US FDA.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts